References

• Zheng, Q., & Wang, X. (2025). Alzheimer's disease: Insights into pathology, molecular mechanisms, and therapy. Protein & Cell, 16(2), 83–120. https://doi.org/10.1093/procel/pwae026
• Jack, C. R., Jr., Andrews, J. S., Beach, T. G., Buracchio, T., Dunn, B., Graf, A., Hansson, O., Ho, C., Jagust, W., McDade, E., Molinuevo, J. L., Okonkwo, O. C., Pani, L., Rafii, M. S., Scheltens, P., Siemers, E., Snyder, H. M., Sperling, R., Teunissen, C. E., . . . Carrillo, M. C. (2024). Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup. Alzheimer's & Dementia, 20(8), 5143–5169. https://doi.org/10.1002/alz.13859
• Alzheimer's Association. (2025). 2025 Alzheimer's disease facts and figures. Alzheimer's & Dementia, 21(4), Article e70235. https://doi.org/10.1002/alz.70235
• Cummings, J., Apostolova, L., Rabinovici, G. D., Atri, A., Aisen, P., Greenberg, S., Hendrix, S., Selkoe, D., Weiner, M., Petersen, R. C., & Salloway, S. (2023). Lecanemab: Appropriate use recommendations. The Journal of Prevention of Alzheimer's Disease, 10(3), 362–377. https://doi.org/10.14283/jpad.2023.30